Bruno Vigneron Photographer

  • Galleries
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Home
  • Blog
  • Port-Folio
  • Contact
  • Instagram
  • About
  • Prints
  • Facebook
  • Twitter
x
Science All Galleries
Download
twitterlinkedinfacebook

Etienne Binant CEO Biom' Up 12 images Created 16 May 2018

View: 100 | All

Loading ()...

  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-10.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-11.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-12.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-13.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-14.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-4.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-5.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-6.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-3.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-7.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-8.jpg
  • Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€
    E_Bin-9.jpg